Prolonged graft survival induced by CTLA4IG-gene transfection combined with FTY720 administration in rat heart grafting.
Kita
Y
Y
Department of Experimental Surgery and Bioengineering, National Children's Medical Research Center, Tokyo, Japan.
Li
X K
XK
Funeshima
N
N
Enosawa
S
S
Tamura
A
A
Hayashi
S
S
Suzuki
K
K
Kazui
T
T
Amemiya
H
H
Suzuki
S
S
D000069594:Abatacept; D000818:Animals; D015703:Antigens, CD; D000943:Antigens, Differentiation / Q000235:genetics / Q000627:therapeutic use*; D060908:CTLA-4 Antigen; D003131:Combined Modality Therapy; D000068876:Fingolimod Hydrochloride; D015316:Genetic Therapy; D006085:Graft Survival; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D018796:Immunoconjugates; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D011409:Propylene Glycols / Q000627:therapeutic use*; D051381:Rats; D011917:Rats, Inbred Lew; D011919:Rats, Inbred Strains; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use; D013110:Sphingosine / Q000031:analogs & derivatives; D014162:Transfection; D014184:Transplantation, Homologous
D015703:Antigens, CD; D000943:Antigens, Differentiation; D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human; C556708:Ctla4 protein, rat; D018796:Immunoconjugates; D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D011993:Recombinant Fusion Proteins; D000069594:Abatacept; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine